Back to Journals » Core Evidence » Volume 14 » Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy
Please verify you are not a robot.
Back to Journals » Core Evidence » Volume 14 » Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy
Please verify you are not a robot.